[Eosinophils in otorhinolaryngology: friend or foe?]

Eosinophile in der HNO-Heilkunde: Freund oder Feind?

Drug-related side effects Granulocytes Homeostasis Inflammation Rhinosinusitis

Journal

HNO

ISSN: 1433-0458

Titre abrégé: HNO

Pays: Germany

ID NLM: 2985099R

Informations de publication

Date de publication:
04 Mar 2024

Historique:

accepted: 06 02 2024

medline: 4 3 2024

pubmed: 4 3 2024

entrez: 4 3 2024

Statut: aheadofprint

Résumé

This article summarizes the essential aspects of current knowledge about eosinophils, classifies eosinophilia in terms of the dimensions healthy or harmful reaction, takes a specific look at eosinophils in the field of otorhinolaryngology, and gives recommendations for diagnostic workup and therapeutic intervention in case of proven eosinophilia, particularly as an adverse drug reaction. The thoughts are inspired by communications at the 29th Congress of the European Rhinologic Society in Sofia, Bulgaria, 2023. Der vorliegende Artikel fasst die wesentlichen Aspekte des aktuellen Wissens um eosinophile Granulozyten zusammen, ordnet die Eosinophilie in die Dimensionen gesunde oder schädigende Reaktion ein, wirft einen besonderen Blick auf das Gebiet HNO-Heilkunde in Bezug auf Eosinophile und gibt Handlungsempfehlungen zur Diagnostik und therapeutischen Intervention bei einer nachgewiesenen Eosinophilie auch und insbesondere als unerwünschte Arzneimittelwirkung (UAW) unter medikamentöser Therapie. Die Gedanken sind angeregt durch Mitteilungen auf dem 29. Kongress der European Rhinologic Society in Sofia, Bulgarien, 2023.

Autres résumés

Type: Publisher (ger)

Der vorliegende Artikel fasst die wesentlichen Aspekte des aktuellen Wissens um eosinophile Granulozyten zusammen, ordnet die Eosinophilie in die Dimensionen gesunde oder schädigende Reaktion ein, wirft einen besonderen Blick auf das Gebiet HNO-Heilkunde in Bezug auf Eosinophile und gibt Handlungsempfehlungen zur Diagnostik und therapeutischen Intervention bei einer nachgewiesenen Eosinophilie auch und insbesondere als unerwünschte Arzneimittelwirkung (UAW) unter medikamentöser Therapie. Die Gedanken sind angeregt durch Mitteilungen auf dem 29. Kongress der European Rhinologic Society in Sofia, Bulgarien, 2023.

Identifiants

DOI: 10.1007/s00106-024-01442-x PMID: 38436705

pubmed: 38436705

doi: 10.1007/s00106-024-01442-x

pii: 10.1007/s00106-024-01442-x

doi:

Types de publication

English Abstract Journal Article Review

Langues

ger

Sous-ensembles de citation

Informations de copyright

Références

Valent P, Klion AD, Roufosse F et al (2023) Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy 78(1):47–59. https://doi.org/10.1111/all.15544

doi: 10.1111/all.15544 pubmed: 36207764

Steinbach KH, Schick P, Trepel F et al (1979) Estimation of kinetic parameters of neutrophilic, eosinophilic, and basophilic granulocytes in human blood. Blut 39(1):27–38. https://doi.org/10.1007/BF01008072

doi: 10.1007/BF01008072 pubmed: 223692

Carlens J, Wahl B, Ballmaier M, Bulfone-Paus S, Förster R, Pabst O (2009) Common γ‑Chain-Dependent Signals Confer Selective Survival of Eosinophils in the Murine Small Intestine. J Immunol 183(9):5600–5607. https://doi.org/10.4049/jimmunol.0801581

doi: 10.4049/jimmunol.0801581 pubmed: 19843944

Sokollik C, Simon HU (2019) Eosinophile Granulozyten – Physiologie und Pathophysiologie. Z Rheumatol 78(4):306–312. https://doi.org/10.1007/s00393-018-0574-7

doi: 10.1007/s00393-018-0574-7 pubmed: 30627844

Chu VT, Beller A, Rausch S et al (2014) Eosinophils Promote Generation and Maintenance of Immunoglobulin-A-Expressing Plasma Cells and Contribute to Gut Immune Homeostasis. Immunity 40(4):582–593. https://doi.org/10.1016/j.immuni.2014.02.014

doi: 10.1016/j.immuni.2014.02.014 pubmed: 24745334

Wen T, Rothenberg ME (2016) The Regulatory Function of Eosinophils. Microbiol Spectr. https://doi.org/10.1128/microbiolspec.MCHD-0020-2015 (4.5.06)

doi: 10.1128/microbiolspec.MCHD-0020-2015 pubmed: 27780017

Chu VT, Fröhlich A, Steinhauser G et al (2011) Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 12(2):151–159. https://doi.org/10.1038/ni.1981

doi: 10.1038/ni.1981 pubmed: 21217761

Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(23):5591–5596. https://doi.org/10.1242/jcs.116392

doi: 10.1242/jcs.116392 pubmed: 23420197

Varricchi G, Galdiero MR, Loffredo S et al (2018) Eosinophils: The unsung heroes in cancer? OncoImmunology 7(2):e1393134. https://doi.org/10.1080/2162402X.2017.1393134

doi: 10.1080/2162402X.2017.1393134 pubmed: 29308325

Wu D, Molofsky AB, Liang HE et al (2011) Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis. Science 332(6026):243–247. https://doi.org/10.1126/science.1201475

doi: 10.1126/science.1201475 pubmed: 21436399 pmcid: 3144160

Simon HU, Yousefi S, Germic N et al (2020) The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020. Int Arch Allergy Immunol 181(1):11–23. https://doi.org/10.1159/000504847

doi: 10.1159/000504847 pubmed: 31786573

Bousquet J, Chanez P, Lacoste JY et al (1990) Eosinophilic inflammation in asthma. n Engl J Med 323(15):1033–1039. https://doi.org/10.1056/NEJM199010113231505

doi: 10.1056/NEJM199010113231505 pubmed: 2215562

Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU (2003) Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125(6):1660–1669. https://doi.org/10.1053/j.gastro.2003.09.024

doi: 10.1053/j.gastro.2003.09.024 pubmed: 14724818

Elishmereni M, Alenius HT, Bradding P et al (2011) Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 66(3):376–385. https://doi.org/10.1111/j.1398-9995.2010.02494.x

doi: 10.1111/j.1398-9995.2010.02494.x pubmed: 20977491

Elishmereni M, Bachelet I, Nissim Ben-Efraim AH, Mankuta D, Levi-Schaffer F (2013) Interacting mast cells and eosinophils acquire an enhanced activation state in vitro. Allergy 68(2):171–179. https://doi.org/10.1111/all.12059

doi: 10.1111/all.12059 pubmed: 23205534

Gangwar RS, Landolina N, Arpinati L, Levi-Schaffer F (2017) Mast cell and eosinophil surface receptors as targets for anti-allergic therapy. Pharmacol Ther 170:37–63. https://doi.org/10.1016/j.pharmthera.2016.10.010

doi: 10.1016/j.pharmthera.2016.10.010 pubmed: 27773785

Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F (2008) Human mast cell activation by Staphylococcus aureus: interleukin‑8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 76(10):4489–4497. https://doi.org/10.1128/IAI.00270-08

doi: 10.1128/IAI.00270-08 pubmed: 18644875 pmcid: 2546849

Gangwar RS, Levi-Schaffer F (2016) sCD48 is anti-inflammatory in Staphylococcus aureus Enterotoxin B‑induced eosinophilic inflammation. Allergy 71(6):829–839. https://doi.org/10.1111/all.12851

doi: 10.1111/all.12851 pubmed: 26836239

O’Sullivan JA, Wei Y, Carroll DJ et al (2018) Frontline Science: Characterization of a novel mouse strain expressing human Siglec‑8 only on eosinophils. J Leukoc Biol 104(1):11–19. https://doi.org/10.1002/JLB.2HI0917-391R

doi: 10.1002/JLB.2HI0917-391R pubmed: 29601103

Soragni A, Yousefi S, Stoeckle C et al (2015) Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation. Mol Cell 57(6):1011–1021. https://doi.org/10.1016/j.molcel.2015.01.026

doi: 10.1016/j.molcel.2015.01.026 pubmed: 25728769 pmcid: 4904734

Yousefi S, Gold JA, Andina N et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14(9):949–953. https://doi.org/10.1038/nm.1855

doi: 10.1038/nm.1855 pubmed: 18690244

Morshed M, Yousefi S, Stöckle C, Simon HU, Simon D (2012) Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 67(9):1127–1137. https://doi.org/10.1111/j.1398-9995.2012.02868.x

doi: 10.1111/j.1398-9995.2012.02868.x pubmed: 22764833

Ahn SH, Shin KH, Oh JT et al (2023) Calprotectin in chronic rhinosinusitis eosinophil extracellular traps. Int Forum Allergy Rhinol 13(10):1926–1936. https://doi.org/10.1002/alr.23157

doi: 10.1002/alr.23157 pubmed: 36932634

Schwaab J, Lübke J, Reiter A, Metzgeroth G (2022) Idiopathic hypereosinophilic syndrome—diagnosis and treatment. Allergo J Int 31(7):251–256. https://doi.org/10.1007/s40629-022-00221-w

doi: 10.1007/s40629-022-00221-w

Henes JC, Wirths S, Hellmich B (2019) Differential diagnosis of hypereosinophilia. Z Rheumatol 78(4):313–321. https://doi.org/10.1007/s00393-018-0587-2

doi: 10.1007/s00393-018-0587-2 pubmed: 30635705

Larsen RL, Savage NM (2019) How I investigate Eosinophilia. Int J Lab Hematol 41(2):153–161. https://doi.org/10.1111/ijlh.12955

doi: 10.1111/ijlh.12955 pubmed: 30499630

Fokkens WJ, Lund VJ, Hopkins C et al (2020) European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58(Suppl S29):1–464. https://doi.org/10.4193/Rhin20.600

doi: 10.4193/Rhin20.600 pubmed: 32078669

Fokkens WJ, Viskens AS, Backer V et al (2023) EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology 61(3):194–202. https://doi.org/10.4193/Rhin22.489

doi: 10.4193/Rhin22.489 pubmed: 36999780

Kato M, Kephart GM, Talley NJ et al (1998) Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 252(3):418–425. https://doi.org/10.1002/(SICI)1097-0185(199811)252:3〈418::AID-AR10〉3.0.CO;2‑1

doi: 10.1002/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1 pubmed: 9811220

DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME (2006) Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 9(3):210–218. https://doi.org/10.2350/11-05-0130.1

doi: 10.2350/11-05-0130.1 pubmed: 16944979

Noguchi H, Kephart GM, Colby TV, Gleich GJ (1992) Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 140(2):521–528

pubmed: 1739138 pmcid: 1886427

Neves JS, Weller PF (2009) Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr Opin Immunol 21(6):694–699. https://doi.org/10.1016/j.coi.2009.07.011

doi: 10.1016/j.coi.2009.07.011 pubmed: 19709867 pmcid: 2788110

Valent P, Gleich GJ, Reiter A et al (2012) Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol 5(2):157–176. https://doi.org/10.1586/ehm.11.81

doi: 10.1586/ehm.11.81 pubmed: 22475285 pmcid: 3625626

Roufosse FE, Goldman M, Cogan E (2007) Hypereosinophilic syndromes. Orphanet J Rare Dis 2:37. https://doi.org/10.1186/1750-1172-2-37

doi: 10.1186/1750-1172-2-37 pubmed: 17848188 pmcid: 2045078

Gevaert P, Han JK, Smith SG et al (2022) The roles of eosinophils and interleukin‑5 in the pathophysiology of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 12(11):1413–1423. https://doi.org/10.1002/alr.22994

doi: 10.1002/alr.22994 pubmed: 35243803 pmcid: 9790271

De Corso E, Seccia V, Ottaviano G et al (2022) Clinical Evidence of Type 2 Inflammation in Non-allergic Rhinitis with Eosinophilia Syndrome: a Systematic Review. Curr Allergy Asthma Rep 22(4):29–42. https://doi.org/10.1007/s11882-022-01027-0

doi: 10.1007/s11882-022-01027-0 pubmed: 35141844

Petersen H, Götz P, Both M et al (2015) Manifestation of eosinophilic granulomatosis with polyangiitis in head and neck. Rhinology 53(3):277–285. https://doi.org/10.4193/Rhino14.074

doi: 10.4193/Rhino14.074 pubmed: 26363169

Eger K, Pet L, Weersink EJM, Bel EH (2021) Complications of switching from anti-IL‑5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma. J Allergy Clin Immunol Pract 9(7):2913–2915. https://doi.org/10.1016/j.jaip.2021.02.042

doi: 10.1016/j.jaip.2021.02.042 pubmed: 33676050

Shomali W, Gotlib J (2022) World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97(1):129–148. https://doi.org/10.1002/ajh.26352

doi: 10.1002/ajh.26352 pubmed: 34533850

Roufosse F, Weller PF (2010) Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126(1):39–44. https://doi.org/10.1016/j.jaci.2010.04.011

doi: 10.1016/j.jaci.2010.04.011 pubmed: 20538328 pmcid: 2902584

Curtis C, Ogbogu P (2016) Hypereosinophilic Syndrome. Clinic Rev Allerg Immunol 50(2):240–251. https://doi.org/10.1007/s12016-015-8506-7

doi: 10.1007/s12016-015-8506-7

Caminati M, Olivieri B, Dama A et al (2022) Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management. Expert Rev Respir Med 16(7):713–721. https://doi.org/10.1080/17476348.2022.2090342

doi: 10.1080/17476348.2022.2090342 pubmed: 35703018